pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·6h ago·1 min read
save

White House considers executive order to politicize NIH grant approvals

Sep 21, 2026·read at Fierce Biotech ↗RegulatoryNegative

Senior officials met in the Oval Office on Friday to discuss an executive order that would establish an external panel with authority to reject NIH grant applications.

The meeting, reported by The Washington Post, was led by Russell Vought, director of the White House Office of Management and Budget, who argued that the NIH continues to fund projects he described as "woke" and suggested screening grants for diversity, equity and inclusion language.

The administration has already taken steps such as banning researchers from certain countries from accessing NIH databases and reinstating a ban on the use of human fetal tissue from abortions. These actions have disrupted hundreds of clinical trials and disproportionately affected women and early‑career scientists, potentially slowing the development of new medicines.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “White House plans to put NIH grants under political control: reports”

read at Fierce Biotech ↗
405 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health4

related stories

  • Jun 5STAT+: What stripping civil service protections for thousands of federal workers will mean for HHSSTAT
  • Jun 5Tiny HHS office tasked with protecting research participants’ safety is running on fumesSTAT
  • Jun 4STAT+: RFK Jr.’s second year: Vacancies, not vaccinesSTAT
  • Jun 4Scientists uncover a new hiding spot for HIVSTAT
  • Jun 4STAT+: Trump administration to strip job protections of top NIH officials, grants staffSTAT